Annual CFO
-$35.25 M
-$15.05 M-74.49%
December 31, 2023
Summary
- As of February 7, 2025, IPHA annual cash flow from operations is -$35.25 million, with the most recent change of -$15.05 million (-74.49%) on December 31, 2023.
- During the last 3 years, IPHA annual CFO has risen by +$23.87 million (+40.38%).
- IPHA annual CFO is now -115.76% below its all-time high of $223.70 million, reached on December 31, 2015.
Performance
IPHA Cash From Operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash From Operations Formula
CFO = Net Income + Non Cash Expenses + Changes In Working Capital
IPHA Cash From Operations Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -74.5% | - | - |
| 3 y3 years | +40.4% | - | - |
| 5 y5 years | +8.2% | - | - |
IPHA Cash From Operations Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -74.5% | +49.0% | ||||
| 5 y | 5-year | -190.2% | +49.0% | ||||
| alltime | all time | -115.8% | +49.0% |
Innate Pharma SA Cash From Operations History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2023 | -$35.25 M(+74.5%) | - | - |
| Dec 2022 | -$20.20 M(-70.8%) | - | - |
| Dec 2021 | -$69.17 M(+17.0%) | - | - |
| Dec 2020 | -$59.12 M(-251.2%) | - | - |
| Dec 2019 | $39.10 M(-201.8%) | - | - |
| Dec 2018 | -$38.41 M(-29.4%) | - | - |
| Dec 2017 | -$54.43 M(+33.5%) | - | - |
| Dec 2016 | -$40.79 M(-118.2%) | - | - |
| Dec 2015 | $223.70 M(-1027.6%) | - | - |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2014 | -$24.12 M(+65.6%) | - | - |
| Dec 2013 | -$14.57 M(+2.7%) | - | - |
| Dec 2012 | -$14.19 M(-178.3%) | - | - |
| Dec 2011 | $18.11 M(-201.6%) | - | - |
| Dec 2010 | -$17.83 M(+115.4%) | - | - |
| Dec 2009 | -$8.28 M(-61.7%) | - | - |
| Dec 2008 | -$21.64 M(+70.0%) | - | - |
| Dec 2007 | -$12.73 M(-2912.8%) | - | - |
| Dec 2006 | $452.40 K(-105.0%) | - | - |
| Dec 2005 | -$9.02 M | - | - |
FAQ
- What is Innate Pharma SA annual cash flow from operations?
- What is the all time high annual CFO for Innate Pharma SA?
- What is Innate Pharma SA annual CFO year-on-year change?
What is Innate Pharma SA annual cash flow from operations?
The current annual CFO of IPHA is -$35.25 M
What is the all time high annual CFO for Innate Pharma SA?
Innate Pharma SA all-time high annual cash flow from operations is $223.70 M
What is Innate Pharma SA annual CFO year-on-year change?
Over the past year, IPHA annual cash flow from operations has changed by -$15.05 M (-74.49%)